Tag: stage

Entered into secured credit agreement with Innoviva for $15 million maturing in 2029 Announced positive topline results from the Phase 1b/2a diSArm trial for AP-SA02 LOS...

With markets shifting faster and competitors adapting at record speed, AI-enhanced competitive intelligence platforms are more vital than ever for detecting early signals, identifying...

YUPELRI® (revefenacin) net sales of $66.3 million, recognized by Viatris, increased 22% year-over-year1Pivotal Phase 3 CYPRESS study enrollment on track to complete by late...

MALVERN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of its previously announced registered direct offering pursuant to a securities purchase agreement with Janus Henderson Investors, a global asset management firm, for the purchase and sale of 20,000,000 shares of common stock and warrants to purchase up to an aggregate of 20,000,000 shares of common stock at a purchase price of $1.00 per share (closing price on August 7, 2025) and accompanying warrant. The warrants have an exercise price of $1.50 per share, are exercisable immediately upon issuance, and will expire two years following the date of issuance. The warrants are callable by the Company when the VWAP of the Company’s common stock exceeds $2.50 per share for at least five of a trailing 30 trading day period. 

Electromagnetic Geoservices ASA’s (“EMGS” or the “Company”) financial report and market presentation for the second quarter of 2025 are attached.

— Approximately 500,000 U.S. Patients Are Diagnosed with Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung Damage — — BRINSUPRI 10...

Pioneer Consulting is pleased to announce the completion of the marine route surveys for the “Fiber Internet Serving Homes” projects.

The American-made, all-electric RV company expands its vehicle lineup with two new models, the AE.1 Atmos and AE.1 Panos BROOMFIELD, Colo., Aug. 12, 2025 /PRNewswire/...

With Three-Year Revenue Growth of 91%, this Marks the Company's 12th Appearance on the List NASHVILLE, Tenn., Aug. 12, 2025 /PRNewswire/ -- Crown Laboratories, Inc., a...

Yank Technologies expands collaboration with NASA for power interfacing solutions on lunar and planetary surfaces. BROOKLYN, N.Y., Aug. 11, 2025 /PRNewswire/ -- Yank Technologies, the...

SINGAPORE, Aug. 12, 2025 /PRNewswire/ -- FBS, a leading global broker, has published a new market analysis revealing that the long-anticipated altcoin season is...